APO RESEARCH · REPORT
Allergy Immunotherapy
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Product & engineering
Understand the product.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
Selected research
Market Structure
Global Allergy Immunotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.
Read the full market overview
This report provides an overview of the global Allergy Immunotherapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Allergy Immunotherapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Allergy Immunotherapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Allergy Immunotherapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Allergy Immunotherapy Segment by Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti
Allergy Immunotherapy Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapy Segment by Application
Allergic Rhinitis
Allergic Asthma
Others
Allergy Immunotherapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Allergy Immunotherapy market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Allergy Immunotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Allergy Immunotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Applications
- Allergic Rhinitis
- Allergic Asthma
- Others
Companies covered
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- HAL
- Holister Stier
- Leti
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Allergy Immunotherapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Allergy Immunotherapy Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Allergy Immunotherapy Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Allergy Immunotherapy Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Allergy Immunotherapy Market Dynamics
- 2.1 Allergy Immunotherapy Industry Trends
- 2.2 Allergy Immunotherapy Industry Drivers
- 2.3 Allergy Immunotherapy Industry Opportunities and Challenges
- 2.4 Allergy Immunotherapy Industry Restraints
3 Allergy Immunotherapy Market by Manufacturers
- 3.1 Global Allergy Immunotherapy Revenue by Manufacturers (2021-2026)
- 3.2 Global Allergy Immunotherapy Sales by Manufacturers (2021-2026)
- 3.3 Global Allergy Immunotherapy Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Allergy Immunotherapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Allergy Immunotherapy Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Allergy Immunotherapy Manufacturers, Product Type & Application
- 3.7 Global Allergy Immunotherapy Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Allergy Immunotherapy Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Allergy Immunotherapy Players Market Share by Revenue in 2025
- 3.8.3 2025 Allergy Immunotherapy Tier 1, Tier 2, and Tier 3
4 Allergy Immunotherapy Market by Type
- 4.1 Allergy Immunotherapy Type Introduction
- 4.1.1 Subcutaneous Immunotherapy
- 4.1.2 Sublingual Immunotherapy
- 4.2 Global Allergy Immunotherapy Sales by Type
- 4.2.1 Global Allergy Immunotherapy Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Allergy Immunotherapy Sales by Type (2021-2032)
- 4.2.3 Global Allergy Immunotherapy Sales Market Share by Type (2021-2032)
- 4.3 Global Allergy Immunotherapy Revenue by Type
- 4.3.1 Global Allergy Immunotherapy Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Allergy Immunotherapy Revenue by Type (2021-2032)
- 4.3.3 Global Allergy Immunotherapy Revenue Market Share by Type (2021-2032)
5 Allergy Immunotherapy Market by Application
- 5.1 Allergy Immunotherapy Application Introduction
- 5.1.1 Allergic Rhinitis
- 5.1.2 Allergic Asthma
- 5.1.3 Others
- 5.2 Global Allergy Immunotherapy Sales by Application
- 5.2.1 Global Allergy Immunotherapy Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Allergy Immunotherapy Sales by Application (2021-2032)
- 5.2.3 Global Allergy Immunotherapy Sales Market Share by Application (2021-2032)
- 5.3 Global Allergy Immunotherapy Revenue by Application
- 5.3.1 Global Allergy Immunotherapy Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Allergy Immunotherapy Revenue by Application (2021-2032)
- 5.3.3 Global Allergy Immunotherapy Revenue Market Share by Application (2021-2032)
6 Global Allergy Immunotherapy Sales by Region
- 6.1 Global Allergy Immunotherapy Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Allergy Immunotherapy Sales by Region (2021-2032)
- 6.2.1 Global Allergy Immunotherapy Sales by Region (2021-2026)
- 6.2.2 Global Allergy Immunotherapy Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Allergy Immunotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Allergy Immunotherapy Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Allergy Immunotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Allergy Immunotherapy Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Allergy Immunotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Allergy Immunotherapy Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Allergy Immunotherapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Allergy Immunotherapy Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Allergy Immunotherapy Revenue by Region
- 7.1 Global Allergy Immunotherapy Revenue by Region
- 7.1.1 Global Allergy Immunotherapy Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Allergy Immunotherapy Revenue by Region (2021-2026)
- 7.1.3 Global Allergy Immunotherapy Revenue by Region (2027-2032)
- 7.1.4 Global Allergy Immunotherapy Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Allergy Immunotherapy Revenue (2021-2032)
- 7.2.2 North America Allergy Immunotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Allergy Immunotherapy Revenue (2021-2032)
- 7.3.2 Europe Allergy Immunotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Allergy Immunotherapy Revenue (2021-2032)
- 7.4.2 Asia-Pacific Allergy Immunotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Allergy Immunotherapy Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Allergy Immunotherapy Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 ALK-Abello
- 8.1.1 ALK-Abello Company Information
- 8.1.2 ALK-Abello Business Overview
- 8.1.3 ALK-Abello Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 ALK-Abello Allergy Immunotherapy Product Portfolio
- 8.1.5 ALK-Abello Recent Developments
- 8.2 Stallergenes Greer
- 8.2.1 Stallergenes Greer Company Information
- 8.2.2 Stallergenes Greer Business Overview
- 8.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Stallergenes Greer Allergy Immunotherapy Product Portfolio
- 8.2.5 Stallergenes Greer Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Allergy Immunotherapy Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Allergy Therapeutics
- 8.4.1 Allergy Therapeutics Company Information
- 8.4.2 Allergy Therapeutics Business Overview
- 8.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Allergy Therapeutics Allergy Immunotherapy Product Portfolio
- 8.4.5 Allergy Therapeutics Recent Developments
- 8.5 HAL
- 8.5.1 HAL Company Information
- 8.5.2 HAL Business Overview
- 8.5.3 HAL Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 HAL Allergy Immunotherapy Product Portfolio
- 8.5.5 HAL Recent Developments
- 8.6 Holister Stier
- 8.6.1 Holister Stier Company Information
- 8.6.2 Holister Stier Business Overview
- 8.6.3 Holister Stier Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Holister Stier Allergy Immunotherapy Product Portfolio
- 8.6.5 Holister Stier Recent Developments
- 8.7 Leti
- 8.7.1 Leti Company Information
- 8.7.2 Leti Business Overview
- 8.7.3 Leti Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Leti Allergy Immunotherapy Product Portfolio
- 8.7.5 Leti Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Allergy Immunotherapy Value Chain Analysis
- 9.1.1 Allergy Immunotherapy Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Allergy Immunotherapy Production Mode & Process
- 9.2 Allergy Immunotherapy Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Allergy Immunotherapy Distributors
- 9.2.3 Allergy Immunotherapy Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst